Essex Woodlands Management as of Dec. 31, 2018
Portfolio Holdings for Essex Woodlands Management
Essex Woodlands Management holds 8 positions in its portfolio as reported in the December 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Revance Therapeutics (RVNC) | 37.0 | $92M | 3.3M | 27.45 | |
| pSivida | 32.0 | $79M | 42M | 1.89 | |
| Axogen (AXGN) | 22.6 | $56M | 2.7M | 20.43 | |
| MediciNova (MNOV) | 5.9 | $15M | 1.2M | 12.49 | |
| Endologix | 2.2 | $5.4M | 1.3M | 4.26 | |
| Catalyst Biosciences | 0.2 | $625k | 79k | 7.95 | |
| Acura Pharmaceuticals (ACUR) | 0.1 | $215k | 2.0M | 0.11 | |
| Corium Intl | 0.0 | $0 | 0 | 0.00 |
